Table 3 Clinical trials that target IDO/Kyn pathway
From: IDO/kynurenine pathway in cancer: possible therapeutic approaches
| Â | NCT Number | Title | Conditions |
|---|---|---|---|
1 | NCT03047928 | Combination Therapy With Nivolumab and PD L1/IDO Peptide Vaccine to Patients With Metastatic Melanoma | Metastatic Melanoma |
2 | NCT01219348 | IDO Peptide Vaccination for Stage III-IV Non-Small-cell Lung Cancer Patients | NSCLC Lung Cancer |
3 | NCT02967419 | The Study of the Relationship Between TWEAK/Fn14, JAK/STAT3, and IDO in the Immune Microenvironment of Endometrium in Repeated Implantation Failure | Repeated Implantation Failure |
4 | NCT01397916 | IDO Activity in Patients With Chronic Lymphocytic Leukemia (CLL) | CLL |